Literature DB >> 2809232

A rapid turbidimetric assay of phagocytosis and serum opsonizing capacity.

T W Kuypers1, C M Eckmann, R S Weening, D Roos.   

Abstract

An in vitro assay has been developed to measure the opsonizing capacity of serum and the extent of bacterial uptake by phagocytes. Various micro-organisms were preopsonized for 10 min with a serum concentration previously determined to be optimal for the respective types of micro-organism. Subsequently, neutrophils from a healthy donor were added to the preopsonized bacteria in a cuvette of a spectrophotometer. The decrease in turbidity at 400 nm, resulting from the uptake of the micro-organisms by the neutrophils, was measured for 20-30 min and the area under the curves was taken as a measure of the opsonizing capacity of the serum or the phagocytic capacity of the neutrophils. The results correlated well with standard opsonophagocytic assays. By excluding Ca2+ from the buffer of the assay, phagocytosis was distinguished from the combined response of phagocytosis and aggregation. In the presence of Ca2+ ions, both phagocytosis and aggregation contributed to the decrease in turbidity. In the absence of Ca2+, phagocytosis was normal, but aggregation was completely inhibited. Phagocytosis in the absence of Ca2+ was also observed using microscopic and radiometric methods of evaluation. Neutrophils from a patient with a deficiency of leukocyte adhesion molecules, ingested as many bacteria as did normal neutrophils without Ca2+. Experiments with NaF, to inhibit phagocytosis, indicated that the change in turbidity measured in the absence of Ca2+ was mainly caused by phagocytosis, not by attachment of bacteria to the neutrophils. The opsonizing capacity of sera, as determined in our assay, depended both on antibodies and on an intact complement system and the inter-assay variance was less than 5%. We found a close correlation between turbidity changes measured in the presence or absence of Ca2+, suggesting that both phagocytosis and aggregation are opsonin-dependent. This assay is applicable to a variety of opsonizing fluids and micro-organisms, and can be used for assessing the phagocytic capacity of patients' neutrophils as well as for assessing the opsonizing capacity of patients' sera.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2809232     DOI: 10.1016/0022-1759(89)90189-0

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  8 in total

1.  Flow cytometric assay for quantifying opsonophagocytosis and killing of Staphylococcus aureus by peripheral blood leukocytes.

Authors:  E Martin; S Bhakdi
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

2.  The role of Fcgamma receptor polymorphisms and C3 in the immune defence against Neisseria meningitidis in complement-deficient individuals.

Authors:  C A Fijen; R G Bredius; E J Kuijper; T A Out; M De Haas; A P De Wit; M R Daha; J G De Winkel
Journal:  Clin Exp Immunol       Date:  2000-05       Impact factor: 4.330

3.  Immune response capacity after human splenic autotransplantation: restoration of response to individual pneumococcal vaccine subtypes.

Authors:  R Leemans; W Manson; J A Snijder; J W Smit; H J Klasen; T H The; W Timens
Journal:  Ann Surg       Date:  1999-02       Impact factor: 12.969

4.  Immunological properties of recombinant porin of Haemophilus influenzae type b expressed in Bacillus subtilis.

Authors:  R Srikumar; D Dahan; M F Gras; L Saarinen; H Käyhty; M Sarvas; L Vogel; J W Coulton
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

5.  Protection against meningococcal serogroup ACYW disease in complement-deficient individuals vaccinated with the tetravalent meningococcal capsular polysaccharide vaccine.

Authors:  C A Fijen; E J Kuijper; M Drogari-Apiranthitou; Y Van Leeuwen; M R Daha; J Dankert
Journal:  Clin Exp Immunol       Date:  1998-12       Impact factor: 4.330

6.  Antibody deficiency and isolated growth hormone deficiency in a girl with Mulibrey nanism.

Authors:  A Haraldsson; C J van der Burgt; C M Weemaes; B Otten; J A Bakkeren; G B Stoelinga
Journal:  Eur J Pediatr       Date:  1993-06       Impact factor: 3.183

7.  Recombinant human interferon-gamma treatment in severe leucocyte adhesion deficiency.

Authors:  R S Weening; R G Bredius; P P Vomberg; C E van der Schoot; M Hoogerwerf; D Roos
Journal:  Eur J Pediatr       Date:  1992-02       Impact factor: 3.183

8.  Opsonic antibodies to outer membrane protein P2 of nonencapsulated Haemophilus influenza are strain specific.

Authors:  A Troelstra; L Vogel; L van Alphen; P Eijk; H Jansen; J Dankert
Journal:  Infect Immun       Date:  1994-03       Impact factor: 3.441

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.